Related Experiment Video
Updated: Jul 15, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Lauren B Krupp1, Brenda Banwell, Silvia Tenembaum
1National Pediatric MS Center, Stony Brook University Medical Center, Stony Brook, NY 11794-8121, USA. lauren.krupp@stonybrook.edu
Neurology
|April 18, 2007
Summary
Childhood CNS inflammatory demyelinating disorders, like pediatric multiple sclerosis (MS) and acute disseminated encephalomyelitis (ADEM), can now be clinically defined. Further research is needed to confirm the validity of these new diagnostic categories.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Childhood CNS inflammatory demyelinating disorders present diagnostic challenges due to overlapping symptoms.
- Distinguishing between self-limited and chronic conditions requires a standardized classification system.
- Operational definitions are crucial for advancing research in pediatric demyelinating diseases.
Purpose of the Study:
- To develop consensus definitions for major CNS inflammatory demyelinating disorders in children and adolescents.
- To establish an operational classification system for pediatric demyelinating conditions.
- To facilitate future research and improve diagnostic accuracy.
Main Methods:
- Convened an International Pediatric MS Study Group with multidisciplinary experts.
- Held multiple meetings to reach consensus on diagnostic criteria.
- Utilized clinical, biological, and radiographic data to inform definitions.
Main Results:
- Proposed clinical definitions for pediatric multiple sclerosis (MS), acute disseminated encephalomyelitis (ADEM), recurrent ADEM, multiphasic ADEM, neuromyelitis optica, and clinically isolated syndrome.
- The proposed definitions are considered operational for research purposes.
- These definitions require validation through prospective studies.
Conclusions:
- CNS inflammatory demyelinating disorders in pediatric populations can be defined and differentiated.
- The proposed diagnostic categories need further testing to establish their validity and clinical utility.
- Prospective research is essential for refining these classifications.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
01:19Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.